Komori
OLBA DVx HEALTHCARE (2689) · FactContinued Capital Investment and Reduced Investment in Medical Equipment for Loan

Increase in Selling, General and Administrative Expenses Due to Medical Equipment and Other Assets for Lease

First written in FY2019-Q3. 3 of 8 entries say "Advanced", first in FY2019. Latest entry: FY2026.

8entries
8years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseAdvancedFY2019 – FY2020OtherFY2021 – FY2023AdvancedFY20242019: 220192020: 120202021: 120212022: 120222023: 120232024: 120242025: 020252026: 12026
Same theme, other companies
Continued Investment in Rental Assets and Depreciation BurdenA theme 8 companies write about · 3 as a headwind · 5 as a tailwind

The whole theme swung hardest in 2020: 3 of 8 companies on the "Worse" side.

1 other company's latest entry also says "Other".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2026Continued Capital Investment and Reduced Investment in Medical Equipment for LoanAnnual report

    「Total capital investment during the consolidated fiscal year was ¥1,253 million. The main items were ¥9 million for purchases of PCs and servers, ¥187 million for purchases of medical equipment to be provided on loan to hospitals and clinics, ¥40 million for purchases of office equipment, ¥494 million for office renovation and related expenses, and ¥521 million for land acquisition.」

    Capital investment in the Medical Equipment business amounted to ¥1,253 million. Investment in medical equipment provided on loan declined from ¥302 million in the previous fiscal year to ¥187 million, while investment was made in office renovations, land acquisition and related areas.
  2. FY2024AdvancedAnnual report

    「Total capital investment in the Medical Equipment business was ¥485 million. The main items were ¥90 million for purchases of PCs and servers, ¥302 million for purchases of medical equipment to be provided on loan to hospitals and clinics, ¥14 million for purchases of office equipment, and ¥78 million for office renovation and related expenses.」

    Capital investment in the Medical Equipment business amounted to ¥485 million, while investment in medical equipment provided on loan to hospitals and clinics increased from ¥125 million in the previous fiscal year to ¥302 million.
  3. FY2023Renewed expansion of investment in medical equipment provided on loanAnnual report

    「Total capital investment in the Medical Equipment business was ¥274 million. The main items were ¥93 million for purchases of PCs and servers, ¥125 million for purchases of medical equipment to be provided on loan to hospitals and clinics, ¥16 million for purchases of office equipment, and ¥39 million for office renovation and related expenses.」

    Investment in medical equipment provided on loan to hospitals and clinics increased from ¥37 million in the previous fiscal year to ¥125 million, and capital investment in the Medical Equipment business continued.
  4. FY2022Renewed expansion of investment in medical equipment provided on loanAnnual report

    「Total capital investment in the Medical Equipment business was ¥336 million. The main items were ¥104 million for purchases of medical equipment to be provided on loan to hospitals and clinics, ¥35 million for purchases of office equipment, and ¥196 million for office renovation and related expenses.」

    Investment in medical equipment provided on loan increased from ¥37 million in the previous fiscal year to ¥104 million, while capital investment, including office renovations and related expenses, continued.
  5. FY2021Reduced investment in medical equipment provided on loan and continued capital investmentAnnual report

    「Total capital investment in the Medical Equipment business during the consolidated fiscal year was ¥360 million. The main items were ¥37 million for purchases of medical equipment to be provided on loan to hospitals and clinics, ¥21 million for purchases of office equipment, and ¥302 million for office renovation and related expenses.」

    In the Medical Equipment business, investment in medical equipment provided on loan declined from ¥220 million in the previous fiscal year to ¥37 million, while capital investment, including office renovations and related expenses, continued.
  6. FY2020AdvancedAnnual report

    「In the Medical Equipment business, this consisted of ¥220 million for purchases of medical equipment to be provided on loan to hospitals and clinics, ¥4 million for purchases of PCs and servers, ¥18 million for purchases of office equipment, and ¥1,034 million for office renovation and related expenses.」

    Capital investment of ¥1,277 million was made in the Medical Equipment business, including ¥220 million for medical equipment provided on loan to hospitals and clinics, making investment in such equipment more concrete.
  7. FY2019AdvancedAnnual report

    「Capital investment during the consolidated fiscal year consisted of expenses related to the relocation and renovation of offices, purchases of medical equipment to be provided on loan to hospitals and clinics, and other items.」

    Capital investment of ¥440 million was made, including ¥302 million for medical equipment provided on loan to hospitals and clinics. The resulting increase in depreciation expenses became a specific factor contributing to higher SG&A expenses.
  8. FY2019-Q3First statedAnnual report

    「Gross profit in the medical equipment business was broadly in line with the previous year, but selling, general and administrative expenses increased due in part to higher depreciation from the purchase of medical equipment for loan to customers and the absence in the current period of the reversal of the allowance for doubtful accounts recognized in the same period of the previous year.」

    In the Medical Equipment business, it has disclosed in specific terms for the first time that higher depreciation expenses associated with purchases of medical equipment provided on loan and the absence of reversals of allowance for doubtful accounts were factors contributing to higher SG&A expenses.
Moved together

"Expanding the Medical Equipment Business with Consumables Sales as a Growth Driver" moved the same way as this thread, in the same document, in 3 of its 8 moves.

322222★123456
  1. ★This thread
  2. 1Expanding the Medical Equipment Business with Consumables Sales as a Growth Driver3×
  3. 2Expanding the SPD Business Through New Contracts with Large Facilities2×
  4. 3Expanding the Customer Base Through Home-care Rentals2×
  5. 4Deepening Mature Areas and Entering New Healthcare Fields2×
  6. 5Declining Cash Flow from Operating Activities and Cash Balances2×
  7. 6Target management through annual revisions of the medium-term management plan2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
OLBA DVx HEALTHCARE's next results are scheduled for 2026-10-30. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Increase in Selling, General and Administrative Expenses Due to Medical Equipment and Other Assets for Lease | OLBA DVx HEALTHCARE,Inc. (2689) | Komori